A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy

Trial Profile

A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs Octocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Registrational; Therapeutic Use
  • Acronyms LEOPOLD Kids
  • Sponsors Bayer
  • Most Recent Events

    • 27 Jul 2017 This trial has been completed in Latvia.
    • 12 Jul 2017 Planned number of patients changed from 100 to 101.
    • 09 Feb 2017 This trial has been suspended in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top